[go: up one dir, main page]

AR046229A1 - Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura - Google Patents

Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura

Info

Publication number
AR046229A1
AR046229A1 ARP040104059A ARP040104059A AR046229A1 AR 046229 A1 AR046229 A1 AR 046229A1 AR P040104059 A ARP040104059 A AR P040104059A AR P040104059 A ARP040104059 A AR P040104059A AR 046229 A1 AR046229 A1 AR 046229A1
Authority
AR
Argentina
Prior art keywords
pivoxil
cefditoren
highly pure
amorphous
pivoxil cefditoren
Prior art date
Application number
ARP040104059A
Other languages
English (en)
Inventor
Yatendra Kumar
Mohan Prasad
Kaptan Singh
Ashok Prasad
Santosh Richhariya
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of AR046229A1 publication Critical patent/AR046229A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

La presente se relaciona con un proceso para preparar formas amorfa y cristalina altamente puras de pivoxil cefditoren y composiciones farmacéuticas que comprenden formas amorfa y cristalina altamente puras de pivoxil cefditoren. También se relaciona con un método para tratar infecciones utilizando formas amorfa y cristalina altamente puras de pivoxil cefditoren. El pivoxil cefditoren altamente puro tiene una pureza superior a 98.5% y contiene menos de 1.0% de impurezas de isómero E y menos de 1% de la impureza del isómero D2. Reivindicación 6: Un proceso para preparar pivoxil cefditoren cristalino a partir de pivoxil cefditoren amorfo proceso que comprende: a) i) agregar pivoxil cefditoren amorfo a un solvente orgánico que opcionalmente contenga agua y/o ii) agregar un solvente orgánico que opcionalmente contenga agua a pivoxil cefditoren amorfo; b) cristalizar el producto a partir de la mezcla de la reacción; y c) aislar el pivoxil cefditoren cristalino.
ARP040104059A 2003-11-07 2004-11-05 Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura AR046229A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1368DE2003 2003-11-07

Publications (1)

Publication Number Publication Date
AR046229A1 true AR046229A1 (es) 2005-11-30

Family

ID=34566866

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104059A AR046229A1 (es) 2003-11-07 2004-11-05 Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura

Country Status (5)

Country Link
EP (1) EP1689755A2 (es)
JP (1) JP2007510709A (es)
CN (1) CN1902207A (es)
AR (1) AR046229A1 (es)
WO (1) WO2005044824A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459550B2 (en) 2003-07-04 2008-12-02 Orchid Chemicals & Pharmaceuticals Ltd. Process for the preparation of Cefditoren
WO2006024900A1 (en) * 2004-08-31 2006-03-09 Ranbaxy Laboratories Limited Highly pure cefditoren pivoxil
US20090111997A1 (en) * 2005-11-23 2009-04-30 Aaron Cote Method of Generating Amorphous Solid for Water-Insoluble Pharmaceuticals
CN101560216B (zh) * 2009-05-27 2011-06-15 上海交通大学 头孢妥仑酯的制备方法
KR101561963B1 (ko) * 2013-05-23 2015-10-22 영진약품공업 주식회사 세프디토렌 피복실의 신규 결정 형태 및 이의 제조 방법
CN106117244B (zh) * 2016-06-24 2018-10-19 瑞阳制药有限公司 头孢妥仑匹酯的精制方法
CN106243128B (zh) * 2016-07-30 2018-09-04 济南康和医药科技有限公司 一种头孢妥仑匹酯的精制方法
CN107422056B (zh) * 2017-08-17 2020-04-24 山东裕欣药业有限公司 一种特戊酸碘甲酯的气相色谱检测方法及其制备方法
CN109053768A (zh) * 2018-08-07 2018-12-21 中国医药集团总公司四川抗菌素工业研究所 一种无定型头孢妥仑酯的制备方法
CN109336904B (zh) * 2018-11-21 2020-06-09 山东罗欣药业集团股份有限公司 一种头孢妥仑匹酯的制备方法
CN110251467A (zh) * 2019-06-26 2019-09-20 北京济美堂医药研究有限公司 一种无定形态头孢妥仑匹酯组合物的制备方法
CN116332956A (zh) * 2023-01-16 2023-06-27 浙江东邦药业有限公司 一种无定型头孢妥仑匹酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9712072A (pt) * 1996-09-20 1999-08-24 Meiji Seika Kaisha Subst-ncia cristalina de defditoren pivoxil e a produ-Æo da mesma
IL137004A0 (en) * 1998-01-07 2001-06-14 Meiji Seika Kaisha Crystallographically stable amorphous cephalosporin compositions and process for producing the same
JP2001131071A (ja) * 1999-10-29 2001-05-15 Meiji Seika Kaisha Ltd 非晶質および非晶質を含有する医薬組成物

Also Published As

Publication number Publication date
WO2005044824A2 (en) 2005-05-19
CN1902207A (zh) 2007-01-24
JP2007510709A (ja) 2007-04-26
EP1689755A2 (en) 2006-08-16
WO2005044824A3 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
AR046229A1 (es) Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura
ES2803516T3 (es) Una forma cristalina de linezolid
BRPI1011015B8 (pt) método para sintetizar pirfenidona
ES2170732B2 (es) Procedimiento para preparar citalopram purificado
ES2181663T3 (es) Procedimiento para la preparacion de citalopram puro.
BRPI0407149A8 (pt) formas polimórficas de rifaximin, processos para sua produção e seu uso em preparações medicinais
BR0113234A (pt) Polimorfos de um análogo de epotilona
PE20021031A1 (es) Aminoacidos biciclicos o triciclicos condensados
BRPI0412659A (pt) isÈmero c de cci-779, seu processo de preparação, composição farmacêutica compreendendo o mesmo e pacote farmacêutico contendo o referido composto
UA109774C2 (uk) Кристалічні форми саксагліптину та процес його одержання (варіанти)
BRPI0913026A2 (pt) sais e polimeros de um composto de tetraciclina
BR0314133A (pt) Métodos para a preparação, isolamento e purificação de epotilona b e raios x de estruturas de cristal de epotilona b
AR033335A1 (es) Compuestos de acidos 3-propil gama aminobutirico mono y di sustituidos, composicion farmaceutica que los comprende y su uso para fabricar dicha composicion
BR0312152A (pt) método de produção de lipossomos contendo um composto biologicamente ativo, e composição de lipossomos
AR080275A1 (es) Formas solidas de un derivado de n-( fenilmetil) propanamida y procedimientos de preparacion
PE20061422A1 (es) Tigeciclina y metodos para preparar 9-nitrominociclina
AR003973A1 (es) Forma cristalina biodisponible de axetil cefuroxima y proceso para producirla
UY27410A1 (es) Formas novedosas crudas cristalinas
AR048973A1 (es) (4-metoxi-7-morfolin-4-il-benzotiazol-2-il)amida del acido 4-hidroxi-4-metil-piperidin-1-carboxilico. proceso de preparacion y composiciones farmaceuticas
ES2729198T3 (es) Preparación de derivados de pirrolidina
WO2020016847A3 (en) Purification process for preparation of eribulin and intermediates thereof
AR041678A1 (es) Formas cristalinas de clorhidrato de donepezil
BR0315840A (pt) Fosfolipìdeos de anel substituìdo anti-protozoários
AR048937A1 (es) Proceso para preparar bisulfato de atazanavir forma e3 y material de configuracion c
CL2025001273A1 (es) Compuesto bicíclico fusionado

Legal Events

Date Code Title Description
FB Suspension of granting procedure